Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/07/24
Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 05/02/24
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC ColumnsPRNewsWire • 04/22/24
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce ErrorsPRNewsWire • 04/09/24
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase CartridgesPRNewsWire • 03/14/24
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS AccessoryPRNewsWire • 03/13/24
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule CharacterizationPRNewsWire • 02/26/24
Waters Corporation to Present at the TD Cowen 44th Annual Health Care ConferencePRNewsWire • 02/22/24
Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/06/24
Waters Corp beats Q4 sales estimates on strong demand for drug development servicesReuters • 02/06/24
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial ResultsPRNewsWire • 02/06/24